BioNTech SE (BNTX) Event June 06, 2022, 10:10 UTC (10% Negative) BioNTech SE (BNTX) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 5:23 p.m. 🌍 BioNTech SE (BNTX) - Form 6-K Filing Filing Date: 2022-06-06 Accepted: 2022-06-06 06:10:23 Event Type: Clinical Trial Update Event Details: EX-99.1 2 ex991inestasco06june2022.htm EX-99.1 DocumentExhibit 99.1 Positive Phase 1 Data from mRNA-based Individualized Neoantigen Specific Immunothe... 💼 Business Developments: ✅ Partnership/Collaboration❌ Acquisition Activity: Not reported❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Email: Media@biontech.deInvestor
🌍 BioNTech SE (BNTX) - Form 6-K Filing
Filing Date: 2022-06-06
Accepted: 2022-06-06 06:10:23
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: